Ophthalmology
Medicines

Ophthalmology Medicine Supply for Hospitals & International Buyers

Eye disease affects hundreds of millions of people worldwide, with conditions including glaucoma, age-related macular degeneration (AMD), diabetic retinopathy, dry eye syndrome, uveitis and ocular infections placing significant demand on hospital pharmacies and eye clinics. In the GCC and across Africa, the high prevalence of type 2 diabetes creates a corresponding burden of diabetic eye disease, with diabetic retinopathy and diabetic macular oedema requiring specialist medicines not always available through local supply chains. Euro Biom sources ophthalmic medicines from UK-licensed manufacturers and supplies them to hospitals, eye clinics and international distributors under our MHRA Wholesale Dealer Authorisation.

Glaucoma is the leading cause of irreversible blindness globally, and its management requires a range of intraocular pressure-lowering agents. Our portfolio covers all major drug classes: prostaglandin analogues (latanoprost, bimatoprost, travoprost, tafluprost), beta-blockers (timolol, betaxolol), carbonic anhydrase inhibitors (dorzolamide, brinzolamide, acetazolamide), and alpha-2 agonists (brimonidine). Fixed-dose combination eye drops, which improve adherence by reducing the number of bottles a patient must use each day, are also available across several of these classes.

Anti-VEGF injections have transformed the treatment of AMD and diabetic macular oedema, and demand for these agents is rising sharply in the GCC and Africa as ophthalmology services expand. Euro Biom supplies bevacizumab, ranibizumab (Lucentis), aflibercept (Eylea) and faricimab (Vabysmo) for intravitreal use. These are specialist biologics requiring cold-chain handling throughout the supply chain, and our GDP-compliant logistics infrastructure ensures products are maintained at correct temperatures from UK warehouse to international destination.

Corticosteroids, Lubricants, Antimicrobials and Mydriatics

Corticosteroid eye preparations are used in uveitis, post-surgical inflammation and severe allergic eye disease. We supply dexamethasone, prednisolone and betamethasone eye drops, as well as peri-ocular injectable corticosteroids. Specialist sustained-release preparations including the fluocinolone acetonide intravitreal implant (Iluvien) for chronic diabetic macular oedema can be sourced through our named patient framework for international buyers.

Dry eye is one of the most prevalent ophthalmic conditions, affecting a significant proportion of adults in arid GCC climates. Our dry eye range includes ocular lubricants such as hypromellose, sodium hyaluronate, carbomer gels and hydroxypropyl guar formulations. For severe dry eye with a confirmed inflammatory component, ciclosporin 0.1% eye drops (Ikervis) represent an important prescription option, and Euro Biom can supply this through licensed channels where local availability is limited.

Antibiotic eye preparations are commonly required for conjunctivitis, keratitis and post-operative prophylaxis. Our portfolio includes chloramphenicol, fusidic acid, ciprofloxacin, levofloxacin, gentamicin and tobramycin eye drops and ointments. Antiviral ophthalmic treatment for herpes simplex keratitis is covered by aciclovir 3% eye ointment, and antifungal ophthalmic agents can be sourced on a named patient basis for fungal keratitis cases.

Mydriatics and cycloplegics are essential for ophthalmic examination and for managing conditions including uveitis and amblyopia. We supply tropicamide, cyclopentolate, atropine and phenylephrine eye drops in the formulations and concentrations used in clinical practice. These agents are used in outpatient eye clinics, screening programmes and surgical settings, and reliable availability is critical to maintaining efficient patient throughput.

For GCC and African healthcare buyers, the combination of high diabetes prevalence, growing specialist ophthalmology services and local registration gaps creates consistent demand for UK-sourced ophthalmic medicines. Anti-VEGF agents are not always registered or stocked locally, glaucoma drops experience periodic shortages, and branded formulations that patients have been stabilised on may be unavailable through domestic distributors. Euro Biom supplies these products under our named patient and parallel import frameworks, supported by export documentation accepted by regulatory authorities in the UAE, Saudi Arabia, Qatar, Kuwait, Bahrain, Oman and across Africa.